Grau S - Search Results

1

Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013.

Fondevilla E, Grau S, Mojal S, Palomar M, Matas L, Gudiol F; VINCat Group. Fondevilla E, et al. Among authors: grau s. Expert Rev Anti Infect Ther. 2016;14(1):137-44. doi: 10.1586/14787210.2016.1096776. Epub 2015 Oct 14. Expert Rev Anti Infect Ther. 2016. PMID: 26466197 Review.

2

Management of antimicrobial use in the intensive care unit.

Alvarez-Lerma F, Palomar M, Grau S. Alvarez-Lerma F, et al. Among authors: grau s. Drugs. 2001;61(6):763-75. doi: 10.2165/00003495-200161060-00005. Drugs. 2001. PMID: 11398908 Review.

3

Prevalence of nosocomial infections in acute care hospitals in Catalonia (VINCat Program).

Olona M, Limón E, Barcenilla F, Grau S, Gudiol F; VINCat Program. Olona M, et al. Among authors: grau s. Enferm Infecc Microbiol Clin. 2012 Jun;30 Suppl 3:7-12. doi: 10.1016/S0213-005X(12)70090-3. Enferm Infecc Microbiol Clin. 2012. PMID: 22776148

4

Antibiotic consumption at 46 VINCat hospitals from 2007 to 2009, stratified by hospital size and clinical services.

Grau S, Fondevilla E, Mojal S, Palomar M, Vallès J, Gudiol F; VINCat Antimicrobial Group. Grau S, et al. Enferm Infecc Microbiol Clin. 2012 Jun;30 Suppl 3:43-51. doi: 10.1016/S0213-005X(12)70096-4. Enferm Infecc Microbiol Clin. 2012. PMID: 22776154

5

Cost-effectiveness of anidulafungin in confirmed candidaemia and other invasive Candida infections in Spain.

Grau S, Salavert M, Carlos Pozo Laderas J, García Vargas M, Barrueta JA, Mir N. Grau S, et al. J Mycol Med. 2013 Sep;23(3):155-63. doi: 10.1016/j.mycmed.2013.05.004. Epub 2013 Jul 9. J Mycol Med. 2013. PMID: 23849341

6

How to measure and monitor antimicrobial consumption and resistance.

Grau S, Bou G, Fondevilla E, Nicolás J, Rodríguez-Maresca M, Martínez-Martínez L. Grau S, et al. Enferm Infecc Microbiol Clin. 2013 Sep;31 Suppl 4:16-24. doi: 10.1016/S0213-005X(13)70128-9. Enferm Infecc Microbiol Clin. 2013. PMID: 24129285

7

Design of a score to identify hospitalized patients at risk of drug-related problems.

Urbina O, Ferrández O, Grau S, Luque S, Mojal S, Marin-Casino M, Mateu-de-Antonio J, Carmona A, Conde-Estévez D, Espona M, González E, Riu M, Salas E. Urbina O, et al. Among authors: grau s. Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):923-32. doi: 10.1002/pds.3634. Epub 2014 May 10. Pharmacoepidemiol Drug Saf. 2014. PMID: 24817497

8

Relationship between consumption of MRSA-active antibiotics and burden of MRSA in acute care hospitals in Catalonia, Spain.

Grau S, Fondevilla E, Freixas N, Mojal S, Sopena N, Bella F, Gudiol F; VINCat Group. Grau S, et al. J Antimicrob Chemother. 2015 Apr;70(4):1193-7. doi: 10.1093/jac/dku487. Epub 2014 Nov 27. J Antimicrob Chemother. 2015. PMID: 25433010

9

Patient risk factors for developing a drug-related problem in a cardiology ward.

Urbina O, Ferrández O, Luque S, Grau S, Mojal S, Pellicer R, Riu M, Salas E, Comin-Colet J. Urbina O, et al. Among authors: grau s. Ther Clin Risk Manag. 2014 Dec 17;11:9-15. doi: 10.2147/TCRM.S71749. eCollection 2015. Ther Clin Risk Manag. 2014. PMID: 25565852 Free PMC article.

10

Antifungal therapeutic drug monitoring: when, how, and why.

Grau S, Luque S. Grau S, et al. Enferm Infecc Microbiol Clin. 2015 May;33(5):295-7. doi: 10.1016/j.eimc.2015.03.005. Epub 2015 Apr 8. Enferm Infecc Microbiol Clin. 2015. PMID: 25861923 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

446 results

Search Page